Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)

NCT04246801 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Salvat